Search
Rein Therapeutics Inc
RNTXAdd to Watchlist
0.776USD
-0.015-1.92%
Close 07-27 16:00（ET）Quotes delayed by 15 min
21.76MMarket Cap
LossP/E TTM
Rein Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-27The current valuation score of Rein Therapeutics Inc is 8.36, ranking 141 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.41, which is -49.09% below the recent high of -0.21 and -392.82% above the recent low of -2.03.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.